repaglinide has been researched along with Autoimmune Diabetes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carr, RD; Degn, KB; Gall, MA; Rizza, RA; Schmitz, O; Thomsen, MK; Veldhuis, JD; Østergård, T | 1 |
| Dumitrescu, D; Guja, C; Ioacără, S; Ionescu-Tîrgovişte, C; Tomescu, I | 1 |
| Jacobson-Dickman, E; Levitsky, L | 1 |
| Hatorp, V; Oliver, S; Su, CA | 1 |
| Chowdhury, TA; Lasker, SS | 1 |
2 trial(s) available for repaglinide and Autoimmune Diabetes
| Article | Year |
|---|---|
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Glyburide; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Piperidines; Placebos; Potassium Channel Blockers; Somatostatin | 2004 |
Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Carbamates; Cross-Over Studies; Diabetes Mellitus, Type 1; Humans; Hypoglycemic Agents; Infusions, Intravenous; Male; Middle Aged; Piperidines; Tablets | 1998 |
3 other study(ies) available for repaglinide and Autoimmune Diabetes
| Article | Year |
|---|---|
Continuous glucose monitoring: physiologic and pathophysiologic significance.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Circadian Rhythm; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Monitoring, Physiologic; Piperidines; Postprandial Period; Statistics as Topic; Treatment Outcome | 2004 |
Oral agents in managing diabetes mellitus in children and adolescents.
Topics: Administration, Oral; Adolescent; Carbamates; Child; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Piperidines; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2005 |
Subclinical type 1 diabetes.
Topics: Adult; Blood Glucose; Carbamates; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Infectious Mononucleosis; Piperidines; Postprandial Period | 2002 |